|
Antibiotic and Antifongic Agents |
|
||||||||||||||||||||||||||||
|
Applications
Technical inforamtion The culture media, prepared or purchased, are classically autoclaved, cooled to 50°C, then supplemented with antibiotic solutions. Antibiotic solutions may too be applied by vaporisation directly onto agar petri dishes, or included in agar gel preparation. All should be maintained at 4°C for a maximum time of 30 days to maintain their efficacy. Without further indication, antibiotics may be prepared in filter-sterilized distilled water, and stored frozen at –20°C. |
|
||||||||||||||||||||||||||||
|
n-Octyl-b-D-thiogucopyranoside - The most efficient agent to extraction fusion proteins |
|
|
|||||||||
|
Fusion proteins are produced inside cells; outside secreted soluble forms are easily recovered in media, but inside forms need disruption of cells. These insoluble forms found in crystalised bodies require an efficient solubilisation. Conventionnal methods have several drawbacks, like mediocrous yields, denaturation of proteins, time consuming, and reuqirement of specialised instruments like french press… |
This first step is crucial for all further works, caracterisation, purification, biological activity…To that purpose, the n-Octyl-b-D-thiogucopyranoside offers a method of choice to gently break cells (notably E.Coli bacterial wall), releasing then solubilizing the fusion proteins. Yields and quality of fusion proteins overcome results obtained with classic methods, like sonication. |
|
|
| pBR322 |
|
|||
| pBR322 is cloning vector for general use containing ApR and TcR. Besides the by-inactivation cloning sites indicated on the diagram, Bsc I (iso-Cla I) and Hind III are too available. These sites are located in the region promoting tetracyclin. When a reading frame shift occurs, transformants ApRTcS are obtained. | ||||
| Designation | Cat.number | Qty | ||
| pBR322 | UP030302 | 25 µg | ||
| pBR328 |
|
|||
| pBR328 is a cloning vector for general use containing ApR, TcR et CmR. This vector is a derivative of pBR325, his bom site (responsible of mobility) is deleted and so non mobilisable. It suits to most exigents biological applications. | ||||
| Designation | Cat.number | Qty | ||
| pBR328 | UP032802 | 25 µg | ||
| pUC18 |
|
|||
| pAT153 is a cloning vector derivative of pBR325, his bom site (responsible of mobility) is deleted and so non mobilisable. It is better maintained in bacteria than pBR322. Furthermore, the deletion fo 703pb thant contains the region controling the nombre of copies, allow to increase the number of copies of the encoded protein by a factor 1;5 to 3. pAT153 encodes for the resistance to ampicillin and tetracyclin. | ||||
| Designation | Cat.number | Qty | ||
| pAT153 | UP032602 | 25 µg | ||
| pAT153 |
|
|||
| This plamide contain a multiple-cleavage site in the lacZa fragment. Inserts cloned in this site delete the activity of b-Galactosidase, producing white colonies after X-Gal/IPTG staining. Il codes the resistance to ampicillin. | ||||
| Designation | Cat.number | Qty | ||
| pUC18 | UP033002 | 25 µg | ||
|
Contact your local distributor |
|
||
|
|
211
Bis Avenue Kennedy - BP 1140 Tel. (33) (0) 4 70 03 88 55 Fax. (33) (0) 4 70 03 82 60 |
||